Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP

---

Summary

• President's Associate Presidential Professor
• Director, PGY2 Pediatric Pharmacy Residency
• Director, Pediatric Pharmacotherapy Degree Option

---

Publications & Presentations

11. Ropp D L, Johnson P N, Stephens K, Neely S, Chaaban H, Miller J L. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. Journal of perinatology : official journal of the California Perinatal Association. 2024; 44 : 1478-1484

12. Johnson P N, Chang E, Cormack E, Hornaday K, Neely S, Ranallo C, Chaaban H, Garcia-Contreras L, Miller J L. Detectable Concentrations With Inhaled Tobramycin in Critically Ill Infants and Children Following Implementation of Standardized Protocol. The Annals of pharmacotherapy. 2024 : 10600280241282433

13. Flanagan T, Mercer K, Johnson P N, Miller J L, Yousaf F S, Perrine J. Ketamine Use in Adult and Pediatric Patients Receiving Extracorporeal Membrane Oxygenation (ECMO): A Systematic Review. Journal of pharmacy practice. 2024; 37 : 985-994

14. Zelnicek T D, Miller J L, Vijayarajah S, Johnson P N. A Case Series and Review of Literature Describing the Use of Midodrine for Vasopressor Effects in Infants With Congenital Heart Disease. Hospital Pharmacy. 2024; 59 : 544-551

15. Johnson P N, Parman A, Miller J L. Training the next generation of peer reviewers: Steps for guiding pharmacy learners through the peer review process. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2024; 81 : e137-e140

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

6. University of Oklahoma College of Medicine--Department of Pediatrics. Mentor award (for Caitlyn Bradford, PharmD). Date: 2022.


7. American Society of Health-System Pharmacists Fellow (FASHP). Date: 2021.


8. American Association for Colleges of Pharmacy. Walmart Scholar Mentor (for Laura Salemi). Date: 2020.


9. University of Oklahoma Health Sciences Center. President's Associates Presidential Professorship. Date: 2019.


10. American College of Clinical Pharmacy Pediatric Pharmacy Practice and Research Network. Outstanding Practitioner Award. Date: 2018.

Education

1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.


2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.


3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.


4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.

Administrative Assignments

no results